
MREO Earnings & Financial Statements
Mereo BioPharma Group plc
$0.26
-$0.02(-5.45%)
38
Overall
60
Value
27
Tech
28
Quality
Market Cap
$43.92M
Volume
1.09M
52W Range
$0.20 - $0.78
Target Price
$1.75
MREO earnings and financial statements: Mereo BioPharma Group plc's income statement, balance sheet and cash flow statement, annual and quarterly.
MREO Annual Financial Statements
| Fiscal year | 2026 | 2025 | 2025 | 2025 | 2024 |
|---|---|---|---|---|---|
| Revenue | - | $800.0K | $300.0K | - | - |
| Cost of revenue | - | $133.0K | - | - | - |
| Operating income | -$8.77M | -$40.11M | -$10.02M | -$11.20M | -$47.36M |
| EBITDA | -$6.39M | -$40.47M | -$7.00M | -$6.91M | -$42.38M |
| Net income | -$6.72M | -$41.88M | -$7.02M | -$7.36M | -$44.84M |
| EPS (diluted) | - | - | - | $-0.10 | $-0.30 |
| Fiscal year | 2026 | 2025 | 2025 | 2025 | 2024 |
|---|---|---|---|---|---|
| Total assets | $40.61M | $45.92M | $53.60M | $68.32M | $76.39M |
| Total liabilities | $6.56M | $5.00M | $7.00M | $8.24M | $15.42M |
| Shareholders’ equity | $34.05M | $40.92M | $46.60M | $60.08M | $60.97M |
| Cash and equivalents | $36.22M | $40.99M | $48.70M | $62.48M | $69.80M |
| Long-term debt | - | - | - | - | $187.0K |
| Fiscal year | 2026 | 2025 | 2025 | 2025 | 2024 |
|---|---|---|---|---|---|
| Operating cash flow | -$4.31M | -$30.97M | -$23.29M | -$8.33M | -$32.83M |
| Free cash flow | -$4.61M | -$31.29M | -$23.61M | -$8.65M | -$33.53M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MREO | $0.26 | -5.5% | 1.09M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Mereo BioPharma Group plc Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW